State Institute of Diabetes and Endocrinology Luiz Capriglione IEDE

Rio de Janeiro, Brazil

State Institute of Diabetes and Endocrinology Luiz Capriglione IEDE

Rio de Janeiro, Brazil
SEARCH FILTERS
Time filter
Source Type

Dantas J.R.,Federal University of Rio de Janeiro | Dantas J.R.,State Institute of Diabetes and Endocrinology Luiz Capriglione IEDE | Almeida M.H.,Air Force Central Hospital HCA | Barone B.,State Institute of Diabetes and Endocrinology Luiz Capriglione IEDE | And 7 more authors.
Diabetes Research and Clinical Practice | Year: 2013

C peptide (CP) was evaluated in 88 individuals with type 1 diabetes, variable disease duration and multiethnic background. Initially, 28 patients had detectable CP, which persisted in 46.2% after 17.4 ± 4 months. CP decline was associated with ethnicity, HbA1c and baseline CP, but not with GADA, PTPN22 or insulin gene polymorphisms. © 2013 Elsevier Ireland Ltd.


de Almeida M.H.,Federal University of Rio de Janeiro | de Almeida M.H.,Air Force Central Hospital HCA | Dantas J.R.,Federal University of Rio de Janeiro | Dantas J.R.,State Institute of Diabetes and Endocrinology Luiz Capriglione IEDE | And 10 more authors.
Clinics | Year: 2013

Objective: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diabetes and variable disease durations. Method: Eighty-eight patients with a mean disease duration of 8.1 +7.6 years were included and underwent C-peptide measurement before and after glucagon stimulation. Chi-squared and Mann Whitney U-tests were used to compare the variables between groups (all two-tailed, a = 0.05). Spearmans correlation coefficient was used to test the association between the continuous variables. Logistic regression was used for the multivariate analysis. Twenty-eight (31.8%) individuals had significantly detectable C-peptide levels after stimuli, particularly those with a shorter disease duration (p<0.001). Results: Patients with detectable C-peptide levels required lower insulin doses (p<0.009) and had similar HbA1C results (p = 0.182) and fewer chronic complications (p = 0.029). Conclusion: C-peptide detection was common in Type-1 diabetics, particularly shortly after being diagnosed. This result may have clinical implications. © 2013 CLINICS.

Loading State Institute of Diabetes and Endocrinology Luiz Capriglione IEDE collaborators
Loading State Institute of Diabetes and Endocrinology Luiz Capriglione IEDE collaborators